Chronic Kidney Disease stage4 Clinical Trial
Official title:
An Open Label, Single-center, Phase 1 Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Patients With Chronic Kidney Disease
This clinical trial is an open, single-center, phase 1 clinical trial to evaluate the safety of allogeneic bone marrow-derived mesenchymal stem cell injection in patients with chronic kidney disease. The purpose is to evaluate the safety for 12 months after administration of Cellgram-CKD 3 times in 10 patients with chronic kidney disease.
The screening test is performed after the clinical trial subject consents in writing to participate in the clinical trial. Subjects who meet the inclusion/exclusion criteria are registered in the clinical trial, and Cellgram-CKD is injected intravenously by puncturing a vein with a needle. After injecting Cellgram-CKD three times at an interval of 2 weeks (14 days), the subject visits the testing institution at 1 month, 3 months, 6 months, 9 months and 12 months for safety evaluation. However, since the safety of Cellgram-CKD has not been established, proceed as follows. In the first 3 subjects who received the investigational product, if no adverse events of Grade 3 or higher according to the NCI-CTCAE related to the investigational product occur 14 days after the 1st and 2nd administration, and 1 month after the 3rd administration, the remaining subjects were sequentially treated. Register as a member and conduct clinical trials. If an adverse event of Grade 3 or higher according to the NCI-CTCAE standard related to the test drug occurs in two of the first three subjects, the clinical trial is terminated early. is conducted by registering three additional test subjects in the same way as the first. If one or more of the three subjects develops a Grade 3 or higher adverse event related to the investigational product, the clinical trial is terminated early, and the remaining subjects are treated only if all three subjects do not have a Grade 3 or higher adverse reaction related to the investigational product. Register to continue the clinical trial. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05630729 -
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
|
N/A | |
Completed |
NCT03293446 -
AC/DC Study: Acidification Test in Patients With Chronic Kidney Disease and Healthy Controls
|
N/A | |
Completed |
NCT04858854 -
Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2
|
N/A | |
Completed |
NCT05624840 -
Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir
|
||
Recruiting |
NCT05489120 -
Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
|
N/A | |
Completed |
NCT04207203 -
Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study
|
N/A | |
Completed |
NCT05153174 -
Study of Sulphoraphane in Chronic Kidney Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT03582982 -
Flywheel Exercise for CKD
|
N/A | |
Not yet recruiting |
NCT06094920 -
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
|
Phase 4 | |
Not yet recruiting |
NCT03348839 -
Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT04913272 -
Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV
|
Phase 2 | |
Recruiting |
NCT04330807 -
Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease
|
N/A | |
Completed |
NCT05931978 -
Effect of a CKD Dashboard on Patient Activation and Shared Decision Making
|
N/A | |
Recruiting |
NCT05543928 -
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
|
Phase 3 | |
Active, not recruiting |
NCT06037265 -
PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System
|
N/A | |
Completed |
NCT04617431 -
Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
|
N/A | |
Recruiting |
NCT04336033 -
Validation and Evaluation of a Newly Developed Mobile Diet App
|
N/A | |
Recruiting |
NCT05138419 -
A Pragmatic Approach to CKD Patient Education
|
N/A | |
Not yet recruiting |
NCT06394544 -
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
|
N/A | |
Recruiting |
NCT01410617 -
The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
|
Phase 2/Phase 3 |